about
Sarcospan-deficient mice maintain normal muscle functionLimb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase geneParaffin wax embedded muscle is suitable for the diagnosis of muscular dystrophyRbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD)Coexisting muscular dystrophies and epilepsy in children.Clinical and pathological characteristics of four Korean patients with limb-girdle muscular dystrophy type 2B.Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.Conservation of components of the dystrophin complex in Drosophila.Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease.Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected]Phenotypic and immunohistochemical characterization of sarcoglycanopathies.An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients.CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathyLiving with muscular dystrophy: health related quality of life consequences for children and adultsUpregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophagesDysferlin and animal models for dysferlinopathy1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial.Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing resultsA study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients.Molecular diagnosis of muscular dystrophies, focused on limb girdle muscular dystrophies.Limb-girdle muscular dystrophy in the Agarwals: Utility of founder mutations in CAPN3 gene.A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients.Heterogeneity in familial dominant Paget disease of bone and muscular dystrophy.The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B).Muscular dystrophy due to a sarcoglycan deficiency in a female Dobermann dog.Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy.Thrombospondin-1 and disease progression in dysferlinopathy.Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro".Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.Limb Girdle Muscular DystrophiesAsymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrumOn symptomatic heterozygous alpha-sarcoglycan gene mutation carriers
P2860
Q24554300-AF2DD2DD-BA60-4E49-91B1-F373B4E3DF08Q24563710-CC0CF2FF-D808-4FBF-84C7-21F46E8657D4Q28367914-DACDBEAE-6397-4793-B1E1-5228EF6F3D00Q28513387-E487845B-DBC4-477E-BBD7-9E893991635EQ33237767-C823190A-148B-430A-9CCA-48AD7A54B0D5Q33631614-2285F373-95B4-451B-95FC-A2A054229AF5Q33833512-3E32486E-AB32-4222-A635-0AF32502F883Q34052934-F053341A-9987-4991-8F9F-40F6740F3F30Q34103354-9C935C56-01EE-4B56-885A-1CBCFF8865BDQ34713891-EF03D062-8CCF-4D55-8AFB-E3849155A889Q34756344-850F5499-193D-417A-9DC4-E02F014F1D78Q35232488-168F588A-BF6B-4F55-ACCC-4C056C72C65AQ35480081-FBA0DB72-A22C-49A2-848C-0D5ACA227A93Q35632288-FD0E3621-F6B2-4DFF-9C22-F17431E105A7Q35846836-D811C433-8E6F-40CB-BC14-1755BABDB191Q35923265-7E07F39C-0989-498C-95FE-82AE78C2A546Q36085192-75945209-CD22-4AFC-A634-BAFCF6DBC8B1Q36298643-BD96194B-6A59-4AFE-83DD-9BB0292CE0CCQ36932773-E9296EDB-5BC1-4B3D-ADC1-98EAF27C5373Q37555761-3943DA27-C78D-4228-8FD5-78B50A726844Q38089840-7C74CA89-39DF-4BD3-8D04-15C1F3B62854Q38839318-D7D87BE4-B4CF-4BF7-8251-892D05BEBD84Q41823092-697950EE-C1B3-4573-B976-5B4EAA392544Q42648925-B83F3049-FF55-4393-ADE7-20EA7816FEDBQ43916486-9E9B62F1-BE79-4319-A849-789EF7A1C907Q44350367-F6E8DA2C-56B7-49CE-AA6A-950CB0853A99Q46058307-15016DB8-7B2E-4C0F-8E47-35D6FDCDBB68Q46262861-976DAE9D-754B-4C2C-9486-D80307939CB6Q50066457-BC7685AB-E28F-4107-A731-5A98AE70362EQ52021000-5D3C6801-5239-4739-99C4-C7EB164E09C4Q54428202-2334D380-199A-4CF7-8DE2-848044A17EC1Q57390065-891D8D34-F4F7-4C06-B185-3CFDB9794B78Q58052175-27AC0DD6-BCFA-4CA1-9ADF-D64D5D3D6F8AQ58052179-84497E50-06D4-49F1-BB37-5983FC5D5336
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Making sense of the limb-girdle muscular dystrophies.
@ast
Making sense of the limb-girdle muscular dystrophies.
@en
type
label
Making sense of the limb-girdle muscular dystrophies.
@ast
Making sense of the limb-girdle muscular dystrophies.
@en
prefLabel
Making sense of the limb-girdle muscular dystrophies.
@ast
Making sense of the limb-girdle muscular dystrophies.
@en
P2860
P356
P1433
P1476
Making sense of the limb-girdle muscular dystrophies.
@en
P2093
P2860
P304
P356
10.1093/BRAIN/122.8.1403
P407
P478
122 ( Pt 8)
P577
1999-08-01T00:00:00Z